Advertisement

Supply Chain


There are several supply considerations for ASCs and outpatient facilities resuming services during the COVID-19 pandemic, according to Infection Control Consulting Services.

There are currently 109 items listed on the FDA's Drug Shortages list, which ASCs should be mindful of as they reopen centers.

After recommending that hospitals and ambulatory surgery centers postpone surgeries in mid-March in light of the COVID-19 pandemic, the Centers for Medicare & Medicaid Services (CMS) announced guidelines on April 19 that detail how facilities can begin to resume procedures.1

Advertisement
Advertisement
Advertisement